×
MedSchool: Ace Your OSCEsThe Medical Company
 
 
 
 
 
GET - On the App Store
View
Drug Guide
 
 

Fluticasone / Umeclidinium / Vilanterol

 
Bookmark
 View Topic Outline
  •  
    MDI
    Fluticasone / Umeclidinium / Vilanterol
    Trelegy Ellipta 

  • Mechanism of Action

  • Contains a long-acting muscarinic agent (LAMA) and a long-acting beta 2 agonist (LABA) as bronchodilators, as well as an inhaled corticosteroid (ICS) to reduce airway inflammation.

Clinical Use

  • Indications

  • Maintenance therapy for COPD.
  • Adverse Effects
  • Tremor
  • Palpitations
  • Headache
  • Oesophageal candidiasis
  • Dry mouth
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now
   
 
 

Snapshot: Initialising...